BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3592878)

  • 21. Sensitivity, specificity, and predictive values of closed pleural biopsy.
    Poe RH; Israel RH; Utell MJ; Hall WJ; Greenblatt DW; Kallay MC
    Arch Intern Med; 1984 Feb; 144(2):325-8. PubMed ID: 6696570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study of lung cancer with presence of pleural effusion at the time of thoracotomy--cytologic evaluation of a relatively small amount of pleural effusion and prognosis after removal].
    Usuda K; Saito Y; Ota S; Sato M; Takahashi S; Kanma K; Sagawa M; Nagamoto N; Fujimura S; Nakada T
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan; 38(1):30-6. PubMed ID: 2329302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oat-cell bronchial carcinoma. Identification of cells in pleural fluid.
    Spriggs AI; Boddington MM
    Acta Cytol; 1976; 20(6):525-9. PubMed ID: 63205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?
    Brock MV; Hooker CM; Yung R; Guo M; Han Y; Ames SE; Chang D; Yang SC; Mason D; Sussman M; Baylin SB; Herman JG
    Ann Thorac Surg; 2005 Oct; 80(4):1241-7. PubMed ID: 16181847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of combined blind pleural biopsy and cytology in the differential diagnosis of pleural effusions].
    Barthel E; Krecklow B
    Z Erkr Atmungsorgane; 1984; 163(1):61-4. PubMed ID: 6485395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soft tissue aspiration cytopathology.
    Wakely PE; Kneisl JS
    Cancer; 2000 Oct; 90(5):292-8. PubMed ID: 11038426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with closed needle biopsy and pleural fluid cytology in the diagnosis of malignant pleural effusions in Yaounde, Cameroon.
    Kuaban C; Essame-Oyono JL; Lekama-Assiene T; Nlend R
    East Afr Med J; 1995 Oct; 72(10):672-4. PubMed ID: 8904051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytologic diagnosis and chromosome analysis: sensitivity, specificity, accuracy and predictive value in malignant and benign pleural effusions.
    Giazza G; Cosimi MF; Lanero M; Rossi GP; Casagranda I
    Pathologica; 1990; 82(1077):33-40. PubMed ID: 2362783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspiration of the breast and nipple discharge cytology.
    Knight DC; Lowell DM; Heimann A; Dunn E
    Surg Gynecol Obstet; 1986 Nov; 163(5):415-20. PubMed ID: 3775619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients.
    Hsu C
    Diagn Cytopathol; 1987 Mar; 3(1):8-12. PubMed ID: 3568976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
    Lee WY
    Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma.
    Davidson B; Reich R; Lazarovici P; Flørenes VA; Risberg B; Nielsen S; Sert B; Bedrossian C
    Lung Cancer; 2004 May; 44(2):159-65. PubMed ID: 15084380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of the immunoperoxidase slide assay in the diagnosis of malignant pleural effusions in breast cancer.
    Guzman J; Costabel U; Bross KJ; Wiehle U; Grunert F; Schaefer HE
    Acta Cytol; 1988; 32(2):188-92. PubMed ID: 3279712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic yield of closed pleural biopsy in exudative pleural effusion.
    Al-Shimemeri AA; Al-Ghadeer HM; Giridhar HR
    Saudi Med J; 2003 Mar; 24(3):282-6. PubMed ID: 12704505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions.
    Liam CK; Lim KH; Wong CM
    Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations.
    Liu J; Farhood A
    Cancer; 2004 Apr; 102(2):109-14. PubMed ID: 15098255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.